Search

Your search keyword '"A. Viros"' showing total 546 results

Search Constraints

Start Over You searched for: Author "A. Viros" Remove constraint Author: "A. Viros"
546 results on '"A. Viros"'

Search Results

1. The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer

2. SudokuSens: Enhancing Deep Learning Robustness for IoT Sensing Applications using a Generative Approach

3. Attack-Resilient Image Watermarking Using Stable Diffusion

4. High-rate, high-resolution single photon X-ray imaging: Medipix4, a large 4-side buttable pixel readout chip with high granularity and spectroscopic capabilities

9. Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settings

10. Evaluación poblacional del impacto del nivel socioeconómico en los resultados clínicos en pacientes con insuficiencia cardiaca en entornos de atención integrada

12. Molecular characterization of fast-growing melanomas

17. Robust Image Watermarking using Stable Diffusion

19. A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.

24. 3D-CHESS: Decentralized, Distributed, Dynamic, and Context-aware Heterogeneous Sensor Systems

26. Mechanisms of Drug Resistance in Melanoma

27. Transoral Oropharyngeal Resection Classification: Proposal of the SCORL Working Group

28. Clasificación de las resecciones transorales en la orofaringe: propuesta del grupo de trabajo de la Sociedad Catalana de Otorrinolaringología

29. Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma

31. The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer

35. Supplementary Table S4 from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

36. Data from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

37. Data from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

39. Supplementary Figure 4 from Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes

40. Supplementary Figure S1 - S3 from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

42. Supplementary Table S1 from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

43. Supplementary Figure Legends from Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes

44. Supplementary Figure 2 from Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes

45. Supplementary Figure 5 from Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes

46. Supplementary Figure S1 from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

47. Supplementary Methods from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

48. Supplementary Figure 1 from Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes

49. Supplementary Material from Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma

50. Supplementary Figure 3 from Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes

Catalog

Books, media, physical & digital resources